Ampio Pharmaceuticals, Inc. (NYSE:AMPE)

Ampio Pharmaceuticals, Inc. (Ampio), is a development stage biopharmaceutical company. The Company is engaged in discovering and developing pharmaceutical drugs and diagnostic products to identify, treat, and prevent a range of human diseases including metabolic disorders, eye disease, kidney disease, acute and chronic inflammation, and male sexual dysfunction.The Company focuses on developing drugs and diagnostic products which capitalize on its own internal discoveries and its intellectual property. The Company is in its clinical stage of development on three product candidates, which includes Zertane and Optina and Ampion. On March 23, 2011, Ampio acquired DMI BioSciences, Inc. (BioSciences), In December 2011, Ampio acquired all rights, title and interest in and to the manufacturing rights and know-how relating to an oral disintegrating tablet (ODT) for Zertane.

Web site: http://ampiopharma.com/

Last updated July 30, 2012